PP_1170x120_10-25-21

vortioxetine

Takeda, Lundbeck make vortioxetine available in U.S.

Takeda, Lundbeck make vortioxetine available in U.S.

DEERFIELD, Ill. — Trintellix (vortioxetine), a once-daily oral antidepressant indicated for the treatment of major depressive disorder (MDD) in adults, has been rolled out to U.S. pharmacies by Takeda Pharmaceuticals U.S.A. and Lundbeck. The companies recently announced that the trade name for their vortioxetine product in this country would be changed to Trintellix to avoid

Adheris Health